Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.32 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6130582 | 0.92 | CYP3A4 (0.34) | CYP3A4NPSR1ALDH1A1TSHRHSD17B10 | |
| SCHEMBL14027608 | 0.85 | ALDH1A1 (0.33) | NPSR1ALDH1A1TSHRHSD17B10 | |
| SCHEMBL5880354 | 0.81 | NPSR1 (0.33) | CYP3A4NPSR1ALDH1A1 | |
| SCHEMBL14335532 | 0.80 | ALDH1A1 (0.36) | CYP3A4ALDH1A1TSHRMAPT | |
| SCHEMBL4756591 | 0.79 | MGLL (0.31) | — | |
| SCHEMBL4460920 | 0.79 | MGLL (0.31) | — | |
| SCHEMBL2430987 | 0.79 | LPAR3 (0.36) | CYP3A4ALDH1A1TSHRMAPT | |
| SCHEMBL14063664 | 0.79 | MGLL (0.33) | — | |
| SCHEMBL31169360 | 0.79 | CYP3A4 (0.41) | CYP3A4NPSR1ALDH1A1TSHRHSD17B10 | |
| SCHEMBL13759591 | 0.78 | TSHR (0.47) | CYP3A4ALDH1A1TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119909777-A | Photocuring micro-fluidic chip for chromatographic detection and preparation method and application thereof | 易普微流控科技(湖州)有限公司 | 2025-05-02 | — | — | CN | claimed |
| WO-2025067452-A1 | METHODS FOR DEEP UNTARGETED PROFILING OF SPATIAL TRANSCRIPTOME AND PROTEOME IN INTACT TISSUES | WESTLAKE LABORATORY OF LIFE SCIENCES AND BIOMEDICINE (CN) | 2025-04-03 | — | — | WO | claimed |
| CN-119500296-A | Digital micro-fluidic chip integrated with coupling active membrane and preparation method and application thereof | 浙江大学 | 2025-02-25 | — | — | CN | claimed |
| CN-119331562-A | OCA optical adhesive and preparation method thereof | 江西塔益莱高分子材料有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-118420824-B | Hyper-dispersant for water-based pigment color paste and preparation method thereof | 无锡米科思新材料科技有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-118420824-A | Hyper-dispersant for water-based pigment color paste and preparation method thereof | 无锡米科思新材料科技有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-117143290-B | Dispersing resin for LCD optical diffusion film and preparation method thereof | 江西塔益莱高分子材料有限公司 | 2024-07-19 | — | — | CN | claimed |
| CN-118325509-A | Weather-resistant photovoltaic adhesive film and preparation process thereof | 苏州市新广益电子股份有限公司 | 2024-07-12 | — | — | CN | claimed |
| US-20240150390-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-05-09 | — | — | US | claimed |
| CN-117916572-A | Method for physical expansion of a sample and use thereof | 西湖大学 | 2024-04-19 | — | — | CN | claimed |
| CN-111628220-A | Electrolyte additive, electrolyte containing additive and lithium ion battery | 合肥国轩高科动力能源有限公司 | 2020-09-04 | — | — | CN | claimed |
| CN-111297781-A | Stem cell active agent for enhancing cell activity and preparation method thereof | 成都吱吖科技有限公司 | 2020-06-19 | — | — | CN | claimed |
| CN-110993948-A | Battery electrode binder | 孙爱芬 | 2020-04-10 | — | — | CN | claimed |
| WO-2020046210-A1 | A MOLECULARLY IMPRINTED POLYMER AND METHOD OF MAKING THE SAME | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2020-03-05 | — | — | WO | claimed |
| CN-110713369-A | Sculpture cement and preparation method thereof | 苏州金螳螂文化发展股份有限公司 | 2020-01-21 | — | — | CN | claimed |
| US-20080039342-A1 | PROCESS FOR TRANSITION METAL-CATALYZED ELECTROCHEMICAL ALLYLIC ALKYLATION ON AN ELECTRODE ARRAY DEVICE | COMBIMATRIX CORPORATION (US) | 2008-02-14 | — | — | US | claimed |
| JP-2006522140-A | — | — | 2006-09-28 | — | — | JP | claimed |
| EP-1608380-A2 | POLYMERIC DRUG AGENTS FOR THE TREATMENT OF FIBROTIC DISORDERS | Vectramed, Inc. (US) | 2005-12-28 | — | — | EP | claimed |
| WO-2004089311-A2 | POLYMERIC DRUG AGENTS FOR THE TREATMENT OF FIBROTIC DISORDERS | VECTRAMED, INC. (US) | 2004-10-21 | — | — | WO | claimed |
| WO-2004087669-A1 | NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO. LTD. (JP) | 2004-10-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150390-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | PAICS, COASY, CDS2 | CYP3A4 4467/4885NPSR1 2580/4885ALDH1A1 4101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.